Press Release CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement 6 hours ago
Press Release CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder Jul 27